Abbott Laboratories (TSX:ABT)

Abbott Laboratories Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	-	7,616	6,896	9,882	9,799
Short-Term Investments	-	351	383	288	450
Trading Asset Securities	-	1	-	-	-
Cash & Short-Term Investments	7,733	7,968	7,279	10,170	10,249
Cash Growth	-2.95%	9.47%	-28.43%	-0.77%	43.38%
Receivables	-	6,925	6,565	6,218	6,487
Inventory	-	6,194	6,570	6,173	5,157
Prepaid Expenses	-	2,179	2,087	2,251	2,054
Other Current Assets	-	390	169	412	292
Total Current Assets	-	23,656	22,670	25,224	24,239
Property, Plant & Equipment	-	11,733	11,276	10,278	10,112
Long-Term Investments	-	573	485	468	512
Goodwill	-	23,108	23,679	22,799	23,231
Other Intangible Assets	-	6,647	8,815	10,454	12,739
Long-Term Deferred Tax Assets	-	15,384	5,975	-	-
Other Long-Term Assets	-	313	314	5,215	4,363
Total Assets	-	81,414	73,214	74,438	75,196
Accounts Payable	-	4,195	4,295	4,607	4,408
Accrued Expenses	-	6,459	6,543	6,925	6,464
Current Portion of Long-Term Debt	-	1,500	1,080	2,271	754
Current Portion of Leases	-	254	245	230	245
Current Income Taxes Payable	-	594	492	343	306
Other Current Liabilities	-	1,155	1,186	1,113	928
Total Current Liabilities	-	14,157	13,841	15,489	13,105
Long-Term Debt	-	12,676	13,694	14,522	17,296
Long-Term Leases	-	896	949	943	956
Pension & Post-Retirement Benefits	-	1,880	1,964	1,784	2,738
Long-Term Deferred Tax Liabilities	-	512	568	991	1,392
Other Long-Term Liabilities	-	3,392	3,371	3,804	3,685
Total Liabilities	-	33,513	34,387	37,533	39,172
Common Stock	-	25,153	24,869	24,709	24,470
Retained Earnings	-	47,261	37,554	35,257	31,528
Treasury Stock	-	-16,844	-15,981	-15,229	-11,822
Comprehensive Income & Other	-	-7,906	-7,839	-8,051	-8,374
Total Common Equity	50,954	47,664	38,603	36,686	35,802
Minority Interest	-	237	224	219	222
Shareholders' Equity	51,264	47,901	38,827	36,905	36,024
Total Liabilities & Equity	-	81,414	73,214	74,438	75,196
Total Debt	12,975	15,326	15,968	17,966	19,251
Net Cash (Debt)	-5,242	-7,358	-8,689	-7,796	-9,002
Net Cash Per Share	-3.00	-4.21	-4.97	-4.42	-5.03
Filing Date Shares Outstanding	1,747	1,734	1,735	1,738	1,763
Total Common Shares Outstanding	1,739	1,732	1,734	1,738	1,764
Working Capital	-	9,499	8,829	9,735	11,134
Book Value Per Share	29.30	27.52	22.26	21.11	20.29
Tangible Book Value	21,385	17,909	6,109	3,433	-168
Tangible Book Value Per Share	12.30	10.34	3.52	1.98	-0.10
Land	-	528	529	511	525
Buildings	-	4,207	4,161	4,053	4,007
Machinery	-	15,517	15,179	14,164	13,528
Construction In Progress	-	2,488	2,064	1,484	1,304

Source: S&P Global Market Intelligence. Standard template. Financial Sources.